The US Medical Device Plastics Market was valued at $7935.5 Million in 2025 and projected to reach to $11706 Million by 2030, representing a compound annual growth rate of 8.1%. The US medical device plastics market is poised for sustained growth through 2030, supported by increasing healthcare expenditures, technological advancements in polymer science, and rising demand for minimally invasive surgical devices.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The US medical device plastics market is valued at $7,935.5 million in 2025, with strong growth trajectory driven by healthcare innovation and device manufacturing expansion across the nation.
The US market is experiencing an 8.1% CAGR, outpacing the global average of 7.7%, reflecting the country's advanced healthcare infrastructure and high adoption of polymeric materials in medical devices.
The US benefits from well-established FDA regulatory frameworks and quality standards that drive demand for high-performance medical-grade plastics in diagnostic, surgical, and therapeutic applications.
The market is projected to reach $11,706.0 million by 2030, representing a $3,770.5 million increase, driven by aging population demographics and increased healthcare spending in the United States.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | –POLYETHERETHERKETONE (PEEK) (Material) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.7% from 2025 to 2030 |
| Largest Segment | FOSSIL-BASED (Source) |
| Market Size Base Year (Billions) | ~USD 21.96 (2025) |
| Revenue Forecast (Billions) | ~USD 31.82 (2030) |
| Segments Covered | Material, Source, Manufacturing Process, Application |
4 segment dimensions are covered across the global market.
| Segment | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|
| DELIVERY SYSTEMS | 1615 | 1747.9 | 1890.3 | 2043.6 | 2219.2 | 2409.7 | 8.3 |
| DIAGNOSTIC EQUIPMENT | 1977 | 2132 | 2297.3 | 2474.4 | 2676.9 | 2895.5 | 7.9 |
| MEDICAL DEVICE HOUSINGS | 1058.4 | 1139.3 | 1225.5 | 1317.8 | 1423.3 | 1537.2 | 7.8 |
| OTHER APPLICATIONS | 286.7 | 307.3 | 329.1 | 352.4 | 379 | 407.5 | 7.3 |
| POINT-OF-CARE DEVICES | 877.9 | 953.7 | 1035.2 | 1123.3 | 1224.4 | 1334.5 | 8.7 |
| SURGICAL INSTRUMENTS | 1408.4 | 1513.5 | 1625.2 | 1744.6 | 1881.1 | 2028.2 | 7.6 |
| WEARABLE MEDICAL DEVICES | 712 | 775.1 | 843.1 | 916.7 | 1001.2 | 1093.5 | 9 |
| TOTAL | 7935.5 | 8568.8 | 9245.7 | 9972.7 | 10805.1 | 11706 | 8.1 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| JABIL INC. | United States | Public Company | Standard Plastics,Engineering Plastics,Extrusion, |
| FLEX LTD. | United States | Public Company | Engineering plastics – Injection molding,Standard plastics – Injection molding,Engineering plastics – Extrusion & CNC machining, |
| NOLATO AB | Sweden | Public Company | Standard Plastics Components (e.g., primary packaging, labware, basic disposables),Engineering Plastics & Silicone Components (e.g., catheter balloons, complex device parts),Diagnostics & Laboratory Plastics (TreffLab and related labware), |
| TRELLEBORG AB | Sweden | Public Company | Engineering Plastics-based Medical Components,Standard Plastics-based Medical Components,Extrusion-based Medical Solutions, |
| FREUDENBERG GROUP | Germany | Private Company | Engineering plastics components (catheters, hypotubes, specialty needles, surgical parts),Medical tubing (silicone and thermoplastic),Precision-molded plastic parts for diagnostics equipment, |
| VIANT | United States | Public Company | Standard Plastics-linked advertisers,Engineering Plastics-linked advertisers,Diagnostics Equipment advertisers, |
| SMC LTD | United States | Public Company | AI and HPC server platforms for healthcare and diagnostics OEMs,General-purpose rackmount and storage systems for hospitals and labs,Embedded and edge systems for medical IoT and point-of-care devices, |
| GE SHEN CORPORATION | Malaysia | Public Company | Engineering plastics components for diagnostics equipment,Engineering plastics components for surgical instruments,Standard plastics parts for diagnostics equipment, |
Jabil Inc. is a publicly traded U.S. manufacturing company founded in 1966 that employs 135,000 people. The company provides electronics manufacturing services and solutions to various industries.
Flex Ltd. is a publicly traded U.S. manufacturing company founded in 1969 with 149,686 employees. The company provides electronics manufacturing services and supply chain solutions globally.
Nolato AB is a publicly traded Swedish company founded in 1938 with 5,607 employees. The company specializes in polymer-based solutions and components for medical, healthcare, and industrial markets.
Trelleborg AB is a publicly traded Swedish company founded in 1905 with 15,756 employees. The company manufactures engineered polymer solutions and sealing systems for diverse industrial applications.
Freudenberg Group is a private German company founded in 1849 with 50,968 employees. The company produces sealing technologies, vibration control, and other engineered solutions for industrial and automotive markets.
Viant is a publicly traded U.S. company founded in 1999 with 408 employees. The company provides digital marketing and data analytics solutions.
SMC Ltd. is a publicly traded U.S. company founded in 1993 with 6,238 employees. The company manufactures and distributes pneumatic and automation components.
GE Shen Corporation is a publicly traded Malaysian company founded in 1988 with 1,161 employees. The company manufactures electronic components and precision engineering products.
The US medical device plastics market is estimated at $7,935.5 million in 2025.
The US medical device plastics market is forecast to reach $11,706.0 million by 2030.
The US market is expected to grow at a compound annual growth rate of 8.1% from 2025 to 2030.
Key drivers in the US include an aging population, rising chronic disease prevalence, increased adoption of minimally invasive procedures, and strong regulatory and R&D infrastructure.
The US market is significant due to its mature healthcare system, stringent quality standards, substantial R&D investments, and leadership in medical device innovation and manufacturing.
The study involves two major activities in estimating the current market size for the medical device plastics market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Following this, market breakdown and data triangulation were employed to determine the market size of segments and subsegments.
Secondary sources referred to for this research study include financial statements of companies offering medical device plastics and information from various trade, business, and professional associations. Secondary research has been used to obtain critical information about the industry’s value chain, the total pool of key players, market classification, and segmentation according to industry trends to the bottom-most level and regional markets. The secondary data was collected and analyzed to arrive at the overall size of the medical device plastics market, which was validated by primary respondents.
Extensive primary research was conducted after obtaining information regarding the medical device plastics market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and South America. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as chief executive officers (CXOs), vice presidents (VPs), directors from business development, marketing, product development/innovation teams, and related key executives from the medical device plastics industry, as well as vendors, material providers, distributors, and key opinion leaders. Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to material, source, manufacturing process, application, and region segments. Stakeholders from the demand side, such as CIOs, CTOs, CSOs, and installation teams of the customer/end users who are seeking medical device plastics, were interviewed to understand the buyer’s perspective on the suppliers, products, component providers, and their current usage of medical device plastics and future outlook of their business, which will affect the overall market.
Breakup of Primary Research:
To know about the assumptions considered for the study, download the pdf brochure
The research methodology used to estimate the size of medical device plastics market includes the following details. The market sizing of the market was undertaken from the demand side. The market was upsized based on the demand for medical device plastics in different applications at the regional level. Such procurements provide information on the demand aspects of the medical device plastics industry for each application. For each application, all possible segments of the medical device plastics market were integrated and mapped.

After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.
Molded plastic components for medical devices refer to precision-molded parts made from polymers used in products such as diagnostic imaging systems, patient monitors, wearable sensors, and respiratory care devices. These components provide lightweight, durable, and design-flexible solutions that enhance patient comfort and device portability. Manufactured under strict FDA and ISO standards, they ensure safety, performance, and compatibility with cleaning and disinfection processes.
Full forecast, segment splits, and company analysis for all Medical Device Plastics Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report